
Sign up to save your podcasts
Or
Interview with Douglas B. Johnson, MD, author of Chronic Immune-Related Adverse Events Following Adjuvant Anti–PD-1 Therapy for High-risk Resected Melanoma
4.9
1212 ratings
Interview with Douglas B. Johnson, MD, author of Chronic Immune-Related Adverse Events Following Adjuvant Anti–PD-1 Therapy for High-risk Resected Melanoma
137 Listeners
319 Listeners
701 Listeners
500 Listeners
38 Listeners
101 Listeners
289 Listeners
3,339 Listeners
38 Listeners
13 Listeners
16 Listeners
18 Listeners
6 Listeners
1,149 Listeners
30 Listeners
190 Listeners
88 Listeners
514 Listeners
369 Listeners
432 Listeners
19 Listeners
372 Listeners
58 Listeners